Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

Gary S. Sachs, Michael E. Thase, Michael W. Otto, Mark Bauer, David Miklowitz, Stephen R. Wisniewski, Philip Lavori, Barry Lebowitz, Mathew Rudorfer, Ellen Frank, Andrew A. Nierenberg, Maurizio Fava, Charles Bowden, Terence Ketter, Lauren Marangell, Joseph Calabrese, David Kupfer, Jerrold F. Rosenbaum

Research output: Contribution to journalArticle

425 Citations (Scopus)

Abstract

The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) was conceived in response to a National Institute of Mental Health initiative seeking a public health intervention model that could generate externally valid answers to treatment effectiveness questions related to bipolar disorder. STEP-BD, like all effectiveness research, faces many design challenges, including how to do the following: recruit a representative sample of patients for studies of readily available treatments; implement a common intervention strategy across diverse settings; determine outcomes for patients in multiple phases of illness; make provisions for testing as yet undetermined new treatments; integrate adjunctive psychosocial interventions; and avoid biases due to subject drop-out and last-observation-carried-forward data analyses. To meet these challenges, STEP-BD uses a hybrid design to collect longitudinal data as patients make transitions between naturalistic studies and randomized clinical trials. Bipolar patients of every subtype with age ≥ 15 years are accessioned into a study registry. All patients receive a systematic assessment battery at entry and are treated by a psychiatrist (trained to deliver care and measure outcomes in patients with bipolar disorder) using a series of model practice procedures consistent with expert recommendations. At every follow-up visit, the treating psychiatrist completes a standardized assessment and assigns an operationalized clinical status based on DSM-IV criteria. Patients have independent evaluations at regular intervals throughout the study and remain under the care of the same treating psychiatrist while making transitions between randomized care studies and the standard care treatment pathways. This article reviews the methodology used for the selection and certification of the clinical treatment centers, training study personnel, the general approach to clinical management, and the sequential treatment strategies offered in the STEP-BD standard and randomized care pathways for bipolar depression and relapse prevention.

Original languageEnglish (US)
Pages (from-to)1028-1042
Number of pages15
JournalBiological Psychiatry
Volume53
Issue number11
DOIs
StatePublished - Jun 1 2003

Fingerprint

Bipolar Disorder
Psychiatry
Therapeutics
Pragmatic Clinical Trials
National Institute of Mental Health (U.S.)
Patient Advocacy
Patient Transfer
Certification
Standard of Care
Secondary Prevention
Diagnostic and Statistical Manual of Mental Disorders
Registries
Public Health
Observation
Outcome Assessment (Health Care)
Research

Keywords

  • Bipolar depression
  • Bipolar disorder
  • Effectiveness research
  • Relapse prevention

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Sachs, G. S., Thase, M. E., Otto, M. W., Bauer, M., Miklowitz, D., Wisniewski, S. R., ... Rosenbaum, J. F. (2003). Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry, 53(11), 1028-1042. https://doi.org/10.1016/S0006-3223(03)00165-3

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). / Sachs, Gary S.; Thase, Michael E.; Otto, Michael W.; Bauer, Mark; Miklowitz, David; Wisniewski, Stephen R.; Lavori, Philip; Lebowitz, Barry; Rudorfer, Mathew; Frank, Ellen; Nierenberg, Andrew A.; Fava, Maurizio; Bowden, Charles; Ketter, Terence; Marangell, Lauren; Calabrese, Joseph; Kupfer, David; Rosenbaum, Jerrold F.

In: Biological Psychiatry, Vol. 53, No. 11, 01.06.2003, p. 1028-1042.

Research output: Contribution to journalArticle

Sachs, GS, Thase, ME, Otto, MW, Bauer, M, Miklowitz, D, Wisniewski, SR, Lavori, P, Lebowitz, B, Rudorfer, M, Frank, E, Nierenberg, AA, Fava, M, Bowden, C, Ketter, T, Marangell, L, Calabrese, J, Kupfer, D & Rosenbaum, JF 2003, 'Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)', Biological Psychiatry, vol. 53, no. 11, pp. 1028-1042. https://doi.org/10.1016/S0006-3223(03)00165-3
Sachs, Gary S. ; Thase, Michael E. ; Otto, Michael W. ; Bauer, Mark ; Miklowitz, David ; Wisniewski, Stephen R. ; Lavori, Philip ; Lebowitz, Barry ; Rudorfer, Mathew ; Frank, Ellen ; Nierenberg, Andrew A. ; Fava, Maurizio ; Bowden, Charles ; Ketter, Terence ; Marangell, Lauren ; Calabrese, Joseph ; Kupfer, David ; Rosenbaum, Jerrold F. / Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). In: Biological Psychiatry. 2003 ; Vol. 53, No. 11. pp. 1028-1042.
@article{9dae7217dc8844088c0aa8fd99df2bcc,
title = "Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)",
abstract = "The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) was conceived in response to a National Institute of Mental Health initiative seeking a public health intervention model that could generate externally valid answers to treatment effectiveness questions related to bipolar disorder. STEP-BD, like all effectiveness research, faces many design challenges, including how to do the following: recruit a representative sample of patients for studies of readily available treatments; implement a common intervention strategy across diverse settings; determine outcomes for patients in multiple phases of illness; make provisions for testing as yet undetermined new treatments; integrate adjunctive psychosocial interventions; and avoid biases due to subject drop-out and last-observation-carried-forward data analyses. To meet these challenges, STEP-BD uses a hybrid design to collect longitudinal data as patients make transitions between naturalistic studies and randomized clinical trials. Bipolar patients of every subtype with age ≥ 15 years are accessioned into a study registry. All patients receive a systematic assessment battery at entry and are treated by a psychiatrist (trained to deliver care and measure outcomes in patients with bipolar disorder) using a series of model practice procedures consistent with expert recommendations. At every follow-up visit, the treating psychiatrist completes a standardized assessment and assigns an operationalized clinical status based on DSM-IV criteria. Patients have independent evaluations at regular intervals throughout the study and remain under the care of the same treating psychiatrist while making transitions between randomized care studies and the standard care treatment pathways. This article reviews the methodology used for the selection and certification of the clinical treatment centers, training study personnel, the general approach to clinical management, and the sequential treatment strategies offered in the STEP-BD standard and randomized care pathways for bipolar depression and relapse prevention.",
keywords = "Bipolar depression, Bipolar disorder, Effectiveness research, Relapse prevention",
author = "Sachs, {Gary S.} and Thase, {Michael E.} and Otto, {Michael W.} and Mark Bauer and David Miklowitz and Wisniewski, {Stephen R.} and Philip Lavori and Barry Lebowitz and Mathew Rudorfer and Ellen Frank and Nierenberg, {Andrew A.} and Maurizio Fava and Charles Bowden and Terence Ketter and Lauren Marangell and Joseph Calabrese and David Kupfer and Rosenbaum, {Jerrold F.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S0006-3223(03)00165-3",
language = "English (US)",
volume = "53",
pages = "1028--1042",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

AU - Sachs, Gary S.

AU - Thase, Michael E.

AU - Otto, Michael W.

AU - Bauer, Mark

AU - Miklowitz, David

AU - Wisniewski, Stephen R.

AU - Lavori, Philip

AU - Lebowitz, Barry

AU - Rudorfer, Mathew

AU - Frank, Ellen

AU - Nierenberg, Andrew A.

AU - Fava, Maurizio

AU - Bowden, Charles

AU - Ketter, Terence

AU - Marangell, Lauren

AU - Calabrese, Joseph

AU - Kupfer, David

AU - Rosenbaum, Jerrold F.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) was conceived in response to a National Institute of Mental Health initiative seeking a public health intervention model that could generate externally valid answers to treatment effectiveness questions related to bipolar disorder. STEP-BD, like all effectiveness research, faces many design challenges, including how to do the following: recruit a representative sample of patients for studies of readily available treatments; implement a common intervention strategy across diverse settings; determine outcomes for patients in multiple phases of illness; make provisions for testing as yet undetermined new treatments; integrate adjunctive psychosocial interventions; and avoid biases due to subject drop-out and last-observation-carried-forward data analyses. To meet these challenges, STEP-BD uses a hybrid design to collect longitudinal data as patients make transitions between naturalistic studies and randomized clinical trials. Bipolar patients of every subtype with age ≥ 15 years are accessioned into a study registry. All patients receive a systematic assessment battery at entry and are treated by a psychiatrist (trained to deliver care and measure outcomes in patients with bipolar disorder) using a series of model practice procedures consistent with expert recommendations. At every follow-up visit, the treating psychiatrist completes a standardized assessment and assigns an operationalized clinical status based on DSM-IV criteria. Patients have independent evaluations at regular intervals throughout the study and remain under the care of the same treating psychiatrist while making transitions between randomized care studies and the standard care treatment pathways. This article reviews the methodology used for the selection and certification of the clinical treatment centers, training study personnel, the general approach to clinical management, and the sequential treatment strategies offered in the STEP-BD standard and randomized care pathways for bipolar depression and relapse prevention.

AB - The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) was conceived in response to a National Institute of Mental Health initiative seeking a public health intervention model that could generate externally valid answers to treatment effectiveness questions related to bipolar disorder. STEP-BD, like all effectiveness research, faces many design challenges, including how to do the following: recruit a representative sample of patients for studies of readily available treatments; implement a common intervention strategy across diverse settings; determine outcomes for patients in multiple phases of illness; make provisions for testing as yet undetermined new treatments; integrate adjunctive psychosocial interventions; and avoid biases due to subject drop-out and last-observation-carried-forward data analyses. To meet these challenges, STEP-BD uses a hybrid design to collect longitudinal data as patients make transitions between naturalistic studies and randomized clinical trials. Bipolar patients of every subtype with age ≥ 15 years are accessioned into a study registry. All patients receive a systematic assessment battery at entry and are treated by a psychiatrist (trained to deliver care and measure outcomes in patients with bipolar disorder) using a series of model practice procedures consistent with expert recommendations. At every follow-up visit, the treating psychiatrist completes a standardized assessment and assigns an operationalized clinical status based on DSM-IV criteria. Patients have independent evaluations at regular intervals throughout the study and remain under the care of the same treating psychiatrist while making transitions between randomized care studies and the standard care treatment pathways. This article reviews the methodology used for the selection and certification of the clinical treatment centers, training study personnel, the general approach to clinical management, and the sequential treatment strategies offered in the STEP-BD standard and randomized care pathways for bipolar depression and relapse prevention.

KW - Bipolar depression

KW - Bipolar disorder

KW - Effectiveness research

KW - Relapse prevention

UR - http://www.scopus.com/inward/record.url?scp=0038054362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038054362&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(03)00165-3

DO - 10.1016/S0006-3223(03)00165-3

M3 - Article

C2 - 12788248

AN - SCOPUS:0038054362

VL - 53

SP - 1028

EP - 1042

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 11

ER -